Last updated: July 17, 2026

Application No. 18/329,245

CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF

Non-Final OA

Filed

Jun 05, 2023

Priority

Sep 14, 2018 — provisional 62/731,469 +2 more

Examiner

JONES, DAMERON LEVEST

Art Unit

1618

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Board of Trustees of the Leland Stanford Junior University

OA Round

2 (Non-Final)

Interview Optional

— +31.4% interview lift. Examiner has a relatively high allowance rate (68%); +31.4% interview lift. A written response may suffice.

Based on 1079 resolved cases, 2023–2026

Examiner Intelligence

JONES, DAMERON LEVEST View full profile →

Grants 68% — above average

Career Allowance Rate

730 granted / 1079 resolved

+7.7% vs TC avg

Strong +31% interview lift

Without

With

+31.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

40 currently pending

Career history

1122

Total Applications

across all art units

Statute-Specific Performance

§101

0.5%

-39.5% vs TC avg

§103

41.7%

+1.7% vs TC avg

§102

8.0%

-32.0% vs TC avg

§112

37.7%

-2.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1079 resolved cases

Prosecution Timeline

Jun 05, 2023

Application Filed

Feb 20, 2025

Response Filed

Sep 12, 2025

Non-Final Rejection mailed

Dec 11, 2025

Response Filed

Dec 12, 2025

Response Filed

Jun 30, 2026

Request for Continued Examination

Jul 01, 2026

Response after Non-Final Action

Jul 14, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/778,571

Patent 12673083

TREM-1 INHIBITORS FOR THE TREATMENT OF VASO-OCCLUSIONS AND TISSUE INJURIES IN PATIENTS SUFFERING FROM SICKLE CELL DISEASE

4y 1m to grant Granted Jul 07, 2026

18/119,070

Patent 12653913

HER2 BINDERS

3y 3m to grant Granted Jun 16, 2026

17/952,056

Patent 12642883

AN INJECTABLE AND IN-SITU CROSSLINKING HYDROGEL FOR ENDOVASCULAR EMBOLIZATION

3y 8m to grant Granted Jun 02, 2026

17/625,224

Patent 12625147

NOVEL MOLECULAR TOOLS TO VISUALIZE AND TARGET THE CARDIAC CONDUCTION SYSTEM (CCS)

4y 4m to grant Granted May 12, 2026

18/104,037

Patent 12616759

USES OF LABELED HSP90 INHIBITORS

3y 3m to grant Granted May 05, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

68%

Grant Probability

99%

With Interview (+31.4%)

3y 5m (~4m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 1079 resolved cases by this examiner. Grant probability derived from career allowance rate.

CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email